After my recent rant about the hopeless state of chronic tendinitis, I have to point out that it appears doctors may be onto a possible cure. What's slightly weird about this, however, is that the story appears on the NYT's sports page, even though they happen to have a perfectly good health/science page on the same day.
In a nutshell, the idea is to bombard the afflicted tendon with the person's own platelets. Simple enough. However, we haven't had any corporations funding the big clinical trial for this, instead we have professional sports team docs trying it out on their multi-million dollar charges. Presumably that's because there aren't big bucks in it for Pfizer. Come to think of it it's not clear that there's anything here that's patentable.
This is rather reminiscent of how a lot of important technology doesn't get developed until somebody decides it would be useful for war fighting. Antibiotics, your Intertubes, the Global Positioning System, all came out of military research. Will platelet-rich plasma therapy make it from the NFL to poor saps like me? We'll just have to wait and see. But one more reason why we need to get basic clinical science research out of the private sector and organize it in the public interest.
Discussion of public health and health care policy, from a public health perspective. The U.S. spends more on medical services than any other country, but we get less for it. Major reasons include lack of universal access, unequal treatment, and underinvestment in public health and social welfare. We will critically examine the economics, politics and sociology of health and illness in the U.S. and the world.
No comments:
Post a Comment
Comments are moderated. You will have to wait for your comment to appear.